We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > series A funding

News List

Alchemab completes £60m Series A funding to advance novel antibody platform pharmatimes
April 16, 2021
Cambridge, UK-based Alchemab Therapeutics has raised £60m ($82m) in a Series A funding round, in a bid to advance its target-agnostic drug discovery platform.
NewAmsterdam Pharma raises $196m through Series A funding round pharmaceutical-technology
January 18, 2021
Clinical stage company NewAmsterdam Pharma (NAP) has raised $196m (€160m) through Series A funding round to support the full Phase III development of its ApoB and LDL-c lowering small molecule drug, obicetrapib.
OncoOne launches with €13m Series A funding pharmaceutical-technology
March 19, 2020
Austria-based OncoOne closed its Series A funding round with €13m raised. This financing will be used to officially launch the company and support the development of oncology treatments...
Bugworks Research raises $9M in series A funding biospectrumasia
August 20, 2018
Bugworks' novel bacterial topoisomerase inhibitor (NBTI) is highly effective against a very broad spectrum of multi-drug resistant bacterial pathogens
mClinica raises $6.3 million series A funding biospectrumasia
February 20, 2017
mClinica builds digital networks of pharmacies, physicians and patients